Highland Capital Management (Texas)’s Amicus Therapeutics FOLD Stock Holding History

Highland Capital Management (Texas)’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.16M	Hold	93,000	–	–	0.07%	196
2019 Q1	$1.26M	Sell	93,000 -18,100	-16%	-$221K	0.08%	187
2018 Q4	$1.06M	Hold	111,100	–	–	0.08%	154
2018 Q3	$1.34M	Hold	111,100	–	–	0.07%	158
2018 Q2	$1.74M	Sell	111,100 -23,900	-18%	-$361K	0.1%	136
2018 Q1	$2.03M	Sell	135,000 -157,000	-54%	-$2.39M	0.1%	135
2017 Q4	$4.2M	Buy	292,000 +110,100	+61%	+$1.51M	0.19%	109
2017 Q3	$2.74M	Buy	181,900 +156,900	+628%	+$2.08M	0.12%	134
2017 Q2	$252K	Hold	25,000	–	–	0.01%	264
2017 Q1	$178K	Sell	25,000 -13,000	-34%	-$82.2K	0.01%	276
2016 Q4	$189K	Hold	38,000	–	–	0.01%	277
2016 Q3	$281K	Buy	+38,000	New	+$257K	0.01%	279
2016 Q2	–	Sell	-521,900	Closed	-$4.41M	–	252
2016 Q1	$4.41M	Buy	521,900 +338,308	+184%	+$2.4M	0.19%	124
2015 Q4	$1.78M	Buy	183,592 +43,592	+31%	+$393K	0.06%	172
2015 Q3	$1.96M	Sell	140,000 -181,336	-56%	-$2.84M	0.06%	185
2015 Q2	$4.55M	Buy	+321,336	New	+$3.86M	0.09%	163

Other funds holding FOLD

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Highland Capital Management (Texas)'s FOLD Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Amicus Therapeutics (FOLD) position steady in Q2 2019 at 93,000 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #196.

Highland Capital Management (Texas) first reported a position in FOLD in Q2 2015 and has held it in 16 quarters since. The position peaked at $4.55M in Q2 2015. 206 funds tracked by Wall St. Rank hold FOLD as of Q2 2019.

Highland Capital Management (Texas) held 93,000 shares of Amicus Therapeutics worth $1.16M as of Q2 2019.
Highland Capital Management (Texas) left its Amicus Therapeutics share count unchanged in Q2 2019.
Amicus Therapeutics made up 0.07% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #196 holding.
Highland Capital Management (Texas) first reported a position in Amicus Therapeutics in Q2 2015 and has held it in 16 quarters since.
Highland Capital Management (Texas)'s Amicus Therapeutics position peaked at $4.55M in Q2 2015.
206 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.